Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

View source ↗

Summary

The Vallania Study, a case-control study by Freenome Holdings Inc., has completed and is exploring multiomics blood tests for cancer screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Freenome Holdings Inc. | Conditions: Cancer | Status: COMPLETED